All News Archive — Page 4 of 168

David Curfman, MD, poses for a photo with his artwork in his office at The Vanderbilt Neurology Clinic. (photo by Erin O. Smith)
August 27, 2026

What do you find at the intersection of art and medicine?

David Curfman and Lealani Mae Acosta practice neurology at work and create art at home. The ways each discipline informs the other runs deeper than it may seem at first glance.

Nicholas Sellke, MD
August 27, 2026

Male fertility a priority for Nicholas Sellke

Although male fertility is a major focus of his practice, Sellke also treats a wide range of men’s health concerns, including erectile dysfunction, hormonal disorders and sexual health issues.

A. Compared to healthy individuals, psychosis subtype 1 demonstrated significantly larger surface area across the cortex and larger basal ganglia volumes. B. Compared to healthy individuals, psychosis subtype 2 demonstrated widespread lower surface area and cortical thickness, and smaller subcortical volumes. (Hill, L.D., et al. Subtyping psychotic disorders using a data-driven approach reveals divergent cortical and cellular signatures. Mol Psychiatry (2026). https://doi.org/10.1038/s41380-026-03774-2. Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0/. Rights and Permissions: https://tinyurl.com/2e9nxeah.)
August 27, 2026

Brain scan method may improve diagnosis, treatment of psychosis

The study suggests that heterogeneity, or the wide range of symptoms, treatment responses and long-term outcomes observed in patients with various forms of psychosis, may reflect separate illness mechanisms and developmental pathways.

August 27, 2026

AUA names David Penson as next editor of The Journal of Urology

He will be tasked to lead the journal’s editorial strategy and position it for continued impact and relevance in the years ahead.

August 26, 2026

Vanderbilt Health mourns passing of global icon Dolly Parton

Legendary songwriter, singer, actress, author and businesswoman, Parton will be remembered for her lasting impact on the lives of millions through her support of everything from pediatric cancer care to infectious disease research at Vanderbilt Health.

(iStock)
August 26, 2026

Duchenne muscular dystrophy patients are focus of GLP-1 therapy for obesity study

The study will begin enrolling eligible patients in September. Thirty participants, ages 12 and older, will be randomized to receive either a placebo or the GLP-1 receptor agonist semaglutide.